ClinicalTrials.Veeva

Menu

ASk Questions in GYnecologic Oncology (ASQ-GYO)

I

Ira Winer

Status

Enrolling

Conditions

Endometrial Cancer
Vulvar Cancer
Gestational Trophoblastic Disease
Vaginal Cancer
Ovarian Cancer
Cervical Cancer

Treatments

Behavioral: Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List

Study type

Interventional

Funder types

Other

Identifiers

NCT06339827
2023-102

Details and patient eligibility

About

The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also to determine the acceptability of the ASQ-GYO QPL with new gynecologic oncology patients.

Full description

  • Potential participants who are scheduled for a new patient appointment will be contacted via phone or email to determine if they are interested in participating.
  • If a participant is interested, they will choose their preferred method of consenting (phone, email, or in person) and if they would like to complete the pre-visit survey now or at a later time prior to their appointment
  • If consented, all participants will be provided with the pre-survey questionnaire. If eligible, participants will then be randomized to usual care or the intervention (ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL)
  • If randomized to receive the ASQ-QYO QPL, they will be emailed this document and given a paper copy of the ASQ-GYO QPL in the waiting room prior to their visit to ensure they have received the intervention.
  • Directly after the participant's visit, all participants will be asked to complete the post-visit survey on a tablet in the clinic waiting room, or via a secure link in an email within 1 week of the appointment.
  • After completion of the post-visit survey and within one month of their visit, participants who were not randomized to receive the ASQ-GYO QPL will be sent the ASQ-GYO QPL via email so that they may also have access to this resource.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age
  • Understands spoken and written English
  • Able to consent to study participation
  • Biopsy confirmed gynecologic cancer diagnosis (ovarian, endometrial, cervical, vulvar, or vaginal cancer or Gestational Trophoblastic Disease) OR have imaging and/or laboratory findings highly concerning for a cancer diagnosis and have not seen a Gynecologic Oncologist

Exclusion criteria

  • pathologic diagnosis of dysplasia only (cervical, vulvar, or endometrial)
  • History and/or imaging/laboratory findings more indicative of a non-cancer diagnosis
  • Previous treatment discussion with a Gynecologic Oncologist

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List
Experimental group
Description:
Participants are provided with a question prompt list
Treatment:
Behavioral: Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List
No administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List
No Intervention group
Description:
Participants will not be provided with the question prompt list

Trial contacts and locations

1

Loading...

Central trial contact

Ira Winer, MD PhD; Elizabeth Johns, MD MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems